Daniel W. Kulp, PhD
The Wistar Institute has announced the appointment of Daniel W. Kulp, PhD, as Associate Professor in the Vaccine Center and the Translational Tumor Immunology Program.
Dr. Kulp’s research centers on how best to rationally engineer protective immune responses against emerging and harmful infectious diseases using computer-designed vaccines. His goal is to create vaccines and engineered antibody therapies that will eradicate a host of infectious diseases related to human immunodeficiency virus (HIV) and arenaviruses, a family of viruses that include Lassa virus, a disease that causes hemorrhagic fever and affects hundreds of thousands of people in Africa each year. His unique computational and engineering expertise will allow him to translate his work for the development of innovative cancer therapeutics.
“Wistar has a rich history of inventing vaccines and therapeutics, and its Vaccine Center continues to be a leader in vaccine research and development, including many efforts on HIV,” said Dr. Kulp.” ■